Neoadjuvant Twice Daily Chemoradiotherapy for Esophageal Cancer: Treatment-Related Mortality and Long-Term Outcomes
Advances in Radiation Oncology - United States
doi 10.1016/j.adro.2017.05.003
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2017
Authors
Publisher
Elsevier BV